167 related articles for article (PubMed ID: 23289797)
21. Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging.
Li JM; Zhao MX; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
Biomaterials; 2011 Nov; 32(31):7978-87. PubMed ID: 21784514
[TBL] [Abstract][Full Text] [Related]
22. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
[TBL] [Abstract][Full Text] [Related]
23. Gene silencing activity of siRNA polyplexes based on biodegradable polymers.
Varkouhi AK; Lammers T; Schiffelers RM; van Steenbergen MJ; Hennink WE; Storm G
Eur J Pharm Biopharm; 2011 Apr; 77(3):450-7. PubMed ID: 21118719
[TBL] [Abstract][Full Text] [Related]
24. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
Sato Y; Matsui H; Sato R; Harashima H
J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
[TBL] [Abstract][Full Text] [Related]
25. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
26. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
Tsutsumi T; Hirayama F; Uekama K; Arima H
J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
[TBL] [Abstract][Full Text] [Related]
28. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
[TBL] [Abstract][Full Text] [Related]
29. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
[TBL] [Abstract][Full Text] [Related]
30. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
31. Efficient Cellular Knockdown Mediated by siRNA Nanovectors of Gemini Cationic Lipids Having Delocalizable Headgroups and Oligo-Oxyethylene Spacers.
Martínez-Negro M; Kumar K; Barrán-Berdón AL; Datta S; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
ACS Appl Mater Interfaces; 2016 Aug; 8(34):22113-26. PubMed ID: 27508330
[TBL] [Abstract][Full Text] [Related]
32. Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.
Wu SY; Chang HI; Burgess M; McMillan NA
J Control Release; 2011 Nov; 155(3):418-26. PubMed ID: 21315117
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
34. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.
Griesenbach U; Kitson C; Escudero Garcia S; Farley R; Singh C; Somerton L; Painter H; Smith RL; Gill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EW
Respir Res; 2006 Feb; 7(1):26. PubMed ID: 16480492
[TBL] [Abstract][Full Text] [Related]
35. Surface engineering of gold nanoparticles for in vitro siRNA delivery.
Zhao E; Zhao Z; Wang J; Yang C; Chen C; Gao L; Feng Q; Hou W; Gao M; Zhang Q
Nanoscale; 2012 Aug; 4(16):5102-9. PubMed ID: 22782309
[TBL] [Abstract][Full Text] [Related]
36. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
[TBL] [Abstract][Full Text] [Related]
37. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
38. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.
Hossain S; Stanislaus A; Chua MJ; Tada S; Tagawa Y; Chowdhury EH; Akaike T
J Control Release; 2010 Oct; 147(1):101-8. PubMed ID: 20620182
[TBL] [Abstract][Full Text] [Related]
39. Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA.
Maslov MA; Kabilova TO; Petukhov IA; Morozova NG; Serebrennikova GA; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):182-93. PubMed ID: 22138073
[TBL] [Abstract][Full Text] [Related]
40. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.
Song E; Zhu P; Lee SK; Chowdhury D; Kussman S; Dykxhoorn DM; Feng Y; Palliser D; Weiner DB; Shankar P; Marasco WA; Lieberman J
Nat Biotechnol; 2005 Jun; 23(6):709-17. PubMed ID: 15908939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
